v3.26.1
OTHER EVENTS (Details Narrative)
6 Months Ended
Jun. 30, 2026
USD ($)
Sep. 11, 2024
USD ($)
Aug. 23, 2024
Jun. 30, 2026
USD ($)
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Business Combination, Transaction Cost, Excluding Separately Recognized Transaction $ 42,491     $ 42,491
Business Development       957,670
Contribution of Property 2,016,562      
Etimated Framework Price Per Set of ITV-1   580    
Estimated Profits per set of ITV-1   $ 1,120    
Nika Pharmaceuticals Ltd [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Real Estate Investment Property, at Cost $ 2,016,562     $ 2,016,562
Percentage of Ownership of Equity Interest       100.00%
Nika Europe [Member] | Nika Pharmaceuticals Ltd [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Percentage of Ownership At theTimeTransaction     99.99%